<- Go Home
Medios AG
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, parenteral nutrition solutions, and investigational medicinal products. Medios AG was founded in 2016 and is headquartered in Berlin, Germany.
Market Cap
EUR 383.2M
Volume
32.1K
Cash and Equivalents
EUR 81.7M
EBITDA
EUR 49.8M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 113.7M
Profit Margin
6.19%
52 Week High
EUR 18.50
52 Week Low
EUR 13.74
Dividend
N/A
Price / Book Value
0.73
Price / Earnings
22.53
Price / Tangible Book Value
-20.71
Enterprise Value
EUR 335.6M
Enterprise Value / EBITDA
6.37
Operating Income
EUR 31.6M
Return on Equity
3.32%
Return on Assets
2.53
Cash and Short Term Investments
EUR 81.7M
Debt
EUR 34.1M
Equity
EUR 502.9M
Revenue
EUR 1.8B
Unlevered FCF
EUR 317.0M
Sector
Health Care Providers and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium